Eagle Global Advisors LLC Invests $9.61 Million in Veeva Systems Inc. $VEEV

Eagle Global Advisors LLC acquired a new stake in shares of Veeva Systems Inc. (NYSE:VEEV) during the 3rd quarter, HoldingsChannel reports. The institutional investor acquired 32,253 shares of the technology company’s stock, valued at approximately $9,608,000.

Other institutional investors also recently bought and sold shares of the company. Trust Co. of Toledo NA OH acquired a new position in Veeva Systems during the 2nd quarter valued at approximately $29,000. OLD Second National Bank of Aurora purchased a new stake in shares of Veeva Systems during the third quarter valued at $30,000. Legacy Investment Solutions LLC acquired a new position in shares of Veeva Systems in the 2nd quarter valued at $32,000. Maseco LLP acquired a new position in shares of Veeva Systems in the 2nd quarter valued at $35,000. Finally, Cary Street Partners Investment Advisory LLC raised its stake in Veeva Systems by 58.3% in the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 133 shares of the technology company’s stock worth $38,000 after acquiring an additional 49 shares during the last quarter. 88.20% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have weighed in on the company. UBS Group dropped their price target on Veeva Systems from $310.00 to $280.00 and set a “neutral” rating on the stock in a research note on Friday, November 21st. Wells Fargo & Company dropped their target price on Veeva Systems from $341.00 to $333.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 25th. Wall Street Zen lowered shares of Veeva Systems from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Jefferies Financial Group restated a “buy” rating and set a $330.00 price objective on shares of Veeva Systems in a research note on Monday, November 24th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $355.00 price objective on shares of Veeva Systems in a research note on Friday, November 21st. Eighteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Veeva Systems presently has a consensus rating of “Moderate Buy” and an average price target of $308.04.

Veeva Systems Price Performance

Shares of NYSE VEEV opened at $218.43 on Thursday. The stock has a market capitalization of $35.91 billion, a price-to-earnings ratio of 42.50, a PEG ratio of 1.69 and a beta of 1.07. The firm’s 50 day simple moving average is $242.93 and its 200-day simple moving average is $269.89. Veeva Systems Inc. has a 12 month low of $201.54 and a 12 month high of $310.50.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings results on Thursday, November 20th. The technology company reported $2.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.95 by $0.09. The firm had revenue of $0.81 million for the quarter, compared to the consensus estimate of $792.37 million. Veeva Systems had a net margin of 27.93% and a return on equity of 13.68%. The firm’s quarterly revenue was up 16.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.75 earnings per share. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. Analysts anticipate that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Veeva Systems declared that its board has authorized a share repurchase program on Monday, January 5th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the technology company to reacquire up to 5.5% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s management believes its stock is undervalued.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.